Experts and competitors raise doubts about a ConAgra Foods Inc. citizen petition that seeks FDA approval of a qualified health claim linking consumption of whole grains and reduced risk of type 2 diabetes.
Though any authorized claim likely would include a disclaimer softening the stated health benefit, ConAgra’s request may test how far FDA is willing to bend on a QHC, in the wake of a recent First